Symbol
|
RMAS7V | Z09N8Z | RMA5TV | RMBFDV | AAVITQ | Z0A3JZ | ACCCTQ |
---|---|---|---|---|---|---|---|
Nom | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
Sous-jacent
|
Biogen Inc. / Bristol-Myers Squibb Co. / Gilead Sciences Inc. / Johnson & Johnson | Amgen Inc. / Biogen Inc. / Moderna Inc. | Biogen Inc. / Eli Lilly & Co. / Roche AG | Biogen Inc. / BioNTech SE / Moderna Inc. | Biogen Idec Inc. / Johnson & Johnson / Pfizer Inc. | Biogen Inc. / Moderna Inc. | Biogen Inc. / Novartis AG / Roche AG |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
09.09.2025 | 17.06.2025 | 31.12.2025 | 15.07.2025 | 06.03.2026 | 26.09.2025 | 11.02.2027 |
Demande | - | - | - | - | 81,04 | - | 94,99 |
Offre | - | - | - | - | 81,84 | - | 95,79 |